Lestaurtinib (CEP701) is a JAK2 inhibitor that suppresses JAK2/STAT5 signaling and the proliferation of primary erythroid cells from patients with myeloproliferative disorders.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples